COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)

Recruiting now

Conditions studied: Cardiac Toxicity, Lung Cancer Stage III, Lung Cancer Stage II, Radiation Toxicity, Cardiac Disease

In brief

Patients with loco-regional NSCLC planned for curative treatment with chemoradiotherapy will be invited to participate in a prospective study; besides routine treatment, the patients will be followed with an ECG and cardiac MR for at least two years after radiotherapy treatment.

Key facts

Study ID

NCT05258448

Run by

Odense University Hospital

People needed

100

Starts

2015-08-01

Expected to finish

2026-10-01

Last updated by the study team

2023-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 Years
• Inoperable and histologically/cytologically verified NSCLC.
• Planned treatment with curative intent.
• Capable of completing study procedures ECG and Cardiac MR.
• Able of giving written and informed consent before study procedures are initiated.

You may not qualify if…

• Vulnerable patients.
• Patients with operable devices as pacemaker/ICD and cochlear implant or other conditions where MR scan is contraindicated.
• Claustrophobia.

Where it is running

• Odense University Hospital — Odense C, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.